Bookmark and Share

Corporate Factbook - #Kimberly-Clark Corporation ($KMB) Has A Target Price of $121,21




qwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuddiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmrtyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmrtyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmrtyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmrtyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmrtyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmrtyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmrtyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnmqwertyuiopasdfghjklzxcvbnm
 


Corporate Factbook



Kimberly-Clark Corporation



13.04.2018



(KMB)



Market cap.: 37.44Billion| Sector: Consumer Goods | Industry: Personal Products
Sales: 18.26Billion | Income: 2.20Billion

1-Year Price Range: 104.58 - 134.29 | 1-Y Performance: -20.0% | YTD Performance: -12.0%


Yield: 3.77% | P/E: 17,16 | Fwd. P/E 14,34 | P/S: 2,05 | P/B: 59,31

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care, consumer tissue, and professional products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Kotex, U by Kotex, Intimus, Depend, Plenitud, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and Jackson Safety brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Growth
Sales Growth Q/Q

0.80%
EPS Growth
Q/Q

9.00%
EPS Growth This Year


3.30%
EPS Growth Next Year


5.89%
EPS Growth Next 5 Years


7.61%
Sales Growth Past 5 Years

-2.10%
EPS Growth Past 5 Years


8.70%

Returns, Margin and Leverage
Return on Assets

15.20%
Return on Equity

809.20%
Gross Margin

35.90%
Return On Investment

30.20%
Operating Margin

18.10%
Profit Margin

12.50%
Debt-to-Equity Ratio

11,9

Per Share Data
Price


106,16
Analyst Target price

121,21
Cash per Share

1,75
Book Value Per share

1,79
EPS TTM


6,19
EPS Next Year

7,4
Dividend
Payout

59.40%

Valuation
P/E


17,16
Forward
P/E

14,34
Price to Sales

2,05
Price to Book

59,31
PEG


2,26
Beta


0,68
RSI


38,38

Latest Earnings Press Release:

•Fourth quarter 2017 net sales of $4.6 billion increased 1 percent compared to the year-ago period and full-year 2017 net sales of $18.3 billion rose slightly.

•Diluted net income per share for the fourth quarter was $1.75 in 2017 and $1.40 in 2016. Full-year diluted net income per share was $6.40 in 2017 and $5.99 in 2016.

•Fourth quarter adjusted earnings per share were $1.57 in 2017 and $1.45 in 2016. Adjusted earnings per share exclude certain items described later in this news release.

•Full-year adjusted earnings per share were $6.23 in 2017, up 3 percent compared to $6.03 in 2016. The company’s previous guidance was for earnings at the low end of the $6.20 to $6.35 range.
•The company has established a cost savings target of more than $1.5 billion over the 2018 to 2021 time period from its ongoing FORCE (Focused On Reducing Costs Everywhere) program.

•In addition, the company announced a new 2018 Global Restructuring Program to reduce the company’s structural cost base by streamlining and simplifying its manufacturing supply chain and overhead organization. The restructuring is expected to generate annual cost savings of $500 to $550 million by the end of 2021 and accelerate the company’s return to delivering its long-term growth objectives over time.

•Net sales in 2018 are expected to increase 1 to 2 percent. Diluted net income per share for 2018 is anticipated to be $3.90 to $4.50, including charges related to the restructuring. Adjusted earnings per share in 2018 are expected to be $6.90 to $7.20, a year-on-year increase of approximately 11 to 16 percent.

•The company’s Board of Directors has approved a 3.1 percent increase in the quarterly dividend for 2018, which is the 46th consecutive annual increase in the dividend.

Chairman and Chief Executive Officer Thomas J. Falk said, “In 2017, we delivered bottom-line growth in a challenging environment. We also achieved all-time record FORCE cost savings of $450

10-Year Financials
Growth Profitability and Financial Ratios for Kimberly-Clark Corp





Financials










2008-12
2009-12
2010-12
2011-12
2012-12
2013-12
2014-12
2015-12
2016-12
Revenue USD Mil
   19,415  
   19,115  
   19,746  
   20,846  
   19,467  
   19,561  
   19,724  
   18,591  
   18,202  
Gross Margin %
        30.2  
        33.6  
        33.2  
        29.5  
        31.5  
        33.8  
        33.9  
        35.6  
        36.5  
Operating Income USD Mil
      2,547  
      2,825  
      2,773  
      2,442  
      2,377  
      2,903  
      2,521  
      1,613  
      3,317  
Operating Margin %
        13.1  
        14.8  
        14.0  
        11.7  
        12.2  
        14.8  
        12.8  
          8.7  
        18.2  
Net Income USD Mil
      1,690  
      1,884  
      1,843  
      1,591  
      1,750  
      2,142  
      1,526  
      1,013  
      2,166  
Earnings Per Share USD
        4.04  
        4.52  
        4.45  
        3.99  
        4.42  
        5.53  
        4.04  
        2.77  
        5.99  
Dividends USD
        2.32  
        2.40  
        2.64  
        2.80  
        2.96  
        3.24  
        3.36  
        3.52  
        3.68  
Payout Ratio % *
        57.1  
        53.1  
        59.3  
        66.0  
        66.9  
        65.7  
        58.9  
      207.1  
        66.2  
Shares Mil
         419  
         417  
         414  
         399  
         396  
         387  
         377  
         366  
         361  
Book Value Per Share * USD
        9.37  
      12.96  
      14.54  
      13.09  
      12.80  
      12.26  
      11.68  
        0.15  
        0.84  
Operating Cash Flow USD Mil
      2,516  
      3,481  
      2,744  
      2,288  
      3,288  
      3,040  
      2,845  
      2,306  
      3,232  
Cap Spending USD Mil
-        906  
-        848  
-        964  
-        968  
-    1,093  
-        953  
-    1,039  
-    1,056  
-        771  
Free Cash Flow USD Mil
      1,610  
      2,633  
      1,780  
      1,320  
      2,195  
      2,087  
      1,806  
      1,250  
      2,461  
Free Cash Flow Per Share * USD
        3.85  
        6.32  
        4.30  
        4.26  
        5.54  
        5.62  
        5.82  
        3.05  
        6.02  
Working Capital USD Mil
      1,061  
         941  
         990  
         886  
         498  
         702  
-        667  
-        923  
-        731  
Key Ratios -> Profitability









Margins % of Sales
2008-12
2009-12
2010-12
2011-12
2012-12
2013-12
2014-12
2015-12
2016-12
Revenue
100
100
100
100
100
100
100
100
100
COGS
69.83
66.41
66.83
70.49
68.52
66.21
66.12
64.37
63.46
Gross Margin
30.17
33.59
33.17
29.51
31.48
33.79
33.88
35.63
36.54
SG&A
16.95
18.3
18.6
18.04
19.3
18.91
18.8
18.52
18.27
R&D









Other
0.1
0.51
0.53
-0.24
-0.03
0.04
2.3
8.43
0.04
Operating Margin
13.12
14.78
14.04
11.71
12.21
14.84
12.78
8.68
18.22
Net Int Inc & Other
-1.33
-1.3
-1.13
-1.24
-1.37
-1.34
-1.35
-1.5
-1.69
EBT Margin
11.79
13.48
12.91
10.47
10.84
13.5
11.43
7.18
16.53










Profitability
2008-12
2009-12
2010-12
2011-12
2012-12
2013-12
2014-12
2015-12
2016-12
Tax Rate %
27
28.96
30.9
30.23
31.74
31.55
37.96
31.31
30.64
Net Margin %
8.7
9.86
9.33
7.63
8.31
10.13
7.74
5.45
11.9
Asset Turnover (Average)
1.06
1.02
1.01
1.06
1.07
1.09
1.15
1.22
1.24
Return on Assets %
9.25
10.1
9.43
8.11
8.92
11.04
8.86
6.67
14.71
Financial Leverage (Average)
4.66
3.55
3.36
3.69
3.99
3.89
21.3
0
0
Return on Equity %
37.14
40.59
32.55
28.5
34.2
43.53
54.65
365.05
0
Return on Invested Capital %
16.44
19.96
18
15.57
17.13
21.32
18.48
15.75
0
Interest Coverage
0
10.37
11.49
8.88
9.52
11.41
8.94
5.53
10.43

Key Ratios -> Growth










2008-12
2009-12
2010-12
2011-12
2012-12
2013-12
2014-12
2015-12
2016-12
Revenue %









Year over Year
6.29
-1.55
3.3
5.57
1.04
0.42
-6.75
-5.74
-2.09
3-Year Average
6.88
4.51
2.63
2.4
3.29
2.32
-1.83
-4.08
-4.88
5-Year Average
6.24
4.85
4.42
4.48
2.89
1.73
0.63
-1.2
-2.68
10-Year Average
4.67
3.93
3.51
3.68
4.5
3.96
2.72
1.57
0.84
Operating Income %









Year over Year
-2.65
10.91
-1.84
-11.94
9.99
19.43
-21.42
-36.02
105.64
3-Year Average
3.3
10.36
1.96
-1.39
-1.67
4.98
1.07
-15.63
1.12
5-Year Average
1.09
2.42
3.72
3.05
0.53
4.72
-2.25
-10.27
6.32
10-Year Average
3.66
2.4
0.92
0.44
0.87
2.89
0.06
-3.53
4.67
Net Income %









Year over Year
-7.29
11.48
-2.18
-13.67
9.99
22.4
-28.76
-33.62
113.82
3-Year Average
2.52
7.91
0.37
-1.99
-2.43
5.14
-1.38
-16.66
0.37
5-Year Average
-0.05
0.91
3.28
1.19
-0.81
4.85
-4.13
-11.28
6.36
10-Year Average
3.78
1.22
0.23
-0.12
0.44
2.37
-1.64
-4.28
3.75
EPS %









Year over Year
-1.22
11.88
-1.55
-10.34
10.78
25.11
-26.94
-31.44
116.25
3-Year Average
7.19
11.62
2.85
-0.41
-0.74
7.51
0.42
-14.42
2.7
5-Year Average
3.94
4.6
6.29
4.19
1.56
6.48
-2.22
-9.05
8.47
10-Year Average
6.71
3.88
3
2.82
3.22
5.2
1.13
-1.68
6.31
Key Ratios -> Cash Flow









Cash Flow Ratios
2008-12
2009-12
2010-12
2011-12
2012-12
2013-12
2014-12
2015-12
2016-12
Operating Cash Flow Growth % YOY
3.59
38.35
-21.17
-16.62
43.71
-7.54
-6.41
-18.95
40.16
Free Cash Flow Growth % YOY
11.84
63.54
-32.4
-25.84
66.29
-4.92
-13.46
-30.79
96.88
Cap Ex as a % of Sales
4.67
4.44
4.88
4.64
5.61
4.87
5.27
5.68
4.24
Free Cash Flow/Sales %
8.29
13.77
9.01
6.33
11.28
10.67
9.16
6.72
13.52
Free Cash Flow/Net Income
0.95
1.4
0.97
0.83
1.25
0.97
1.18
1.23
1.14

Key Ratios -> Financial Health








Balance Sheet Items (in %)
2008-12
2009-12
2010-12
2011-12
2012-12
2013-12
2014-12
2015-12
2016-12
Cash & Short-Term Investments
2.01
5.14
4.41
3.94
5.57
5.57
5.08
4.17
6.32
Accounts Receivable
13.78
13.36
13.54
13.43
13.29
13.45
14.32
15.37
14.9
Inventory
13.78
10.58
11.95
12.16
11.82
11.8
12.19
12.86
11.5
Other Current Assets
2.57
1.45
1.96
2.9
2.48
3.8
4.22
4.16
2.31
Total Current Assets
32.14
30.53
31.86
32.43
33.16
34.62
35.8
36.56
35.03
Net PP&E
42.38
41.82
42.07
41.55
40.73
42.01
47.4
47.86
49.1
Intangibles
15.16
17.05
18.58
18.61
15.43
15.21
9.71
8.92
9.25
Other Long-Term Assets
10.32
10.6
7.5
7.41
8.08
5.27
5.61
5.2
5.17
Total Assets
100
100
100
100
100
100
100
100
100
Accounts Payable
36.67
10.15
11.27
12.51
12.48
13.94
17.15
17.86
18.14
Short-Term Debt
27.93
3.22
1.76
3.7
5.7
2.01
8.69
11.41
7.88
Taxes Payable
0
0.42
0.53
1.39
1.72
1.8
2.16
2.25
1.8
Accrued Liabilities
45.26
10.91
9.75
7.23
9.75
9.25
10.04
9.47
10.23
Other Short-Term Liabilities
12.69
1.32
3.96
3.44
1.48
4.37
2.77
2.42
2.59
Total Current Liabilities
122.54
26.01
27.26
28.27
31.12
31.38
40.81
43.4
40.65
Long-Term Debt
125.89
25.32
26.15
28.42
25.91
28.9
36.9
41.74
44.77
Other Long-Term Liabilities
-125.89
20.1
16.36
15.82
17.5
13.66
17.51
16.04
15.3
Total Liabilities
0
71.43
69.78
72.51
74.53
73.94
95.22
101.19
100.71
Total Stockholders' Equity
100
28.57
30.22
27.49
25.47
26.06
4.78
-1.19
-0.71
Total Liabilities & Equity
100
100
100
100
100
100
100
100
100

Liquidity/Financial Health
2008-12
2009-12
2010-12
2011-12
2012-12
2013-12
2014-12
2015-12
2016-12
Current Ratio
1.22
1.19
1.19
1.16
1.08
1.12
0.89
0.85
0.88
Quick Ratio
0.6
0.72
0.67
0.62
0.62
0.62
0.48
0.46
0.53
Financial Leverage
4.66
3.55
3.36
3.69
3.99
3.89
21.3
0
0
Debt/Equity
1.26
0.89
0.87
1.03
1.02
1.11
7.72
0
0

Key Ratios -> Efficiency Ratios








Efficiency
2008-12
2009-12
2010-12
2011-12
2012-12
2013-12
2014-12
2015-12
2016-12
Days Sales Outstanding
47.49
48.29
46.56
44.42
42.87
40.47
40.93
40.21
41.05
Days Inventory
66.46
65.06
60.93
58.73
59.97
60.09
57.73
57.97
56.69
Payables Period
38.65
48.04
57.06
57.06
61.59
66.13
72.97
79.73
82.49
Cash Conversion Cycle
75.3
65.31
50.44
46.1
41.25
34.44
25.69
18.45
15.25
Receivables Turnover
7.69
7.56
7.84
8.22
8.51
9.02
8.92
9.08
8.89
Inventory Turnover
5.49
5.61
5.99
6.21
6.09
6.07
6.32
6.3
6.44
Fixed Assets Turnover
2.46
2.44
2.41
2.54
2.61
2.64
2.58
2.57
2.55
Asset Turnover
1.06
1.02
1.01
1.06
1.07
1.09
1.15
1.22
1.24

This is only a part from the Dividend Champions Corporate Factbook. To receivemore Corporate Factbooks just make a small donation and we send you the full PDF with the 10 Highest Yielding Dividend Champions each month to your donation e-mail address. Thank you.

No comments:

Post a Comment

Do you have any questions or notes to this article?
Please let me know your thoughts and we will discuss it.